Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of TGF-beta resistance during malignant progression.

Archives of pharmacal research - 1 Feb 1999

Kim Y S, Yi Y, Choi S G, Kim S J

Abstract excerpt

Transforming growth factor-beta (TGF-beta) is the prototypical multifunctional cytokine, participating in the regulation of vital cellular activities such as proliferation and differentiation as well as a number of basic physiological functions. The effects of TGF-beta are critically dependent on the expression and distribution of a family of TGF-beta receptors, the TGF-beta types I, II, and III. It is now known...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to ErbB Receptors
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasms

Share to Transforming Growth Factor beta

Source

Identifiers

PMID: 10071951
DOI: 10.1007/BF02976427

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of TGF-beta resistance during malignant progression.PMID 10071951Read ↗

Tumor suppressor activity of the TGF-beta pathway in human cancers.Semantic proximity Read ↗

Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.Semantic proximity Read ↗

TGF-β: An emerging player in drug resistanceSemantic proximity Read ↗

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.Semantic proximity Read ↗

Role of transforming growth factor-beta in cancer progression.Semantic proximity Read ↗

The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability.Semantic proximity Read ↗

Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.Semantic proximity Read ↗

TGF-β mediated drug resistance in solid cancerSemantic proximity Read ↗

Transforming Growth Factor- <i>β</i> Signaling in Normal and Malignant HematopoiesisSemantic proximity Read ↗

Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.Semantic proximity Read ↗

Mutational inactivation of <i>TGFBR2</i> in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor β resistant cellsSemantic proximity Read ↗

Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.